BackgroundAbnormal ankle-brachial index (ABI) has been found to be a strong predictor
of mortality in some hemodialysis populations in studies with relatively
short periods of follow-up, lower than 2 years.ObjectiveThis study aimed to assess the predictive value of abnormal ABI as a risk
factor for death among patients on maintenance hemodialysis after a 5-year
follow-up.MethodsA total of 478 patients on hemodialysis for at least 12 months were included
in the study. ABI measurement was performed using a mercury column
sphygmomanometer and portable Doppler. Patients were divided into 3 groups
according to ABI (low: <0.9; normal: 0.9 to 1.3; and high: >1.3) and
followed for a 60-month period.ResultsThe prevalence rates of low, normal and high ABI were 26.8%, 64.6% and 8.6%,
respectively. The 5-year survival rate was lower in the groups with low ABI
(44.1%, P<0.0001) and high ABI (60.8%, P= 0.025) than in the group with
normal ABI (71.7%). Cox regression was used to evaluate the association
between ABI and mortality, adjusting for potential confounders. Using normal
ABI as reference, a low, but not a high ABI was found to be an independent
risk factor for all-cause mortality (HR2.57; 95% CI, 1.84-3.57 and HR 1.62;
95% CI, 0.93-2.83, respectively).Conclusionslong-term survival rates of patients with either low or high ABI were lower
than the one from those with normal ABI. However, after adjustment for
potential confounders, only low ABI persisted as an independent risk factor
for all-cause mortality among hemodialysis patients.